Position in NBIX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$30,472,908
-$3,865,693 QoQ
Shares Held
231,311
-4.5% QoQ
Ownership
0.230%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.18469506422089.ToString("F0")%
Shared 0.ToString("F0")%
None 1.8153049357791027.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $924,834,595 across 59 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,491,173 | $649,111,558 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
77,138 | $45,741,289 | |
| 3 | HLN |
Haleon plc
|
4,022,749 | $40,267,716 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
231,311 | $30,472,908 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,136,022 | $21,039,125 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
805,422 | $19,273,746 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
300,133 | $17,788,881 | |
| 8 | VTRS |
Viatris Inc
|
1,160,097 | $15,672,908 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,472,908 | 231,311 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $34,338,601 | 242,111 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $36,266,610 | 258,346 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $35,738,441 | 284,338 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $28,246,243 | 255,391 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $33,658,033 | 246,579 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $30,005,015 | 260,415 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $32,348,179 | 234,969 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $30,592,584 | 221,814 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $13,574,967 | 103,028 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $12,096,112 | 107,521 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,691,493 | 102,773 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $9,232,679 | 91,214 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $10,778,861 | 90,245 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,319,394 | 87,745 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,780,898 | 90,079 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,727,781 | 103,763 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,858,464 | 92,268 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $28,003,895 | 291,981 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $36,442,056 | 374,456 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $29,548,535 | 303,841 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $31,175,114 | 325,249 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $29,176,095 | 303,412 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $34,285,050 | 281,025 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $20,968,207 | 242,267 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||